Clinical Trial Update: Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing pulpotomy in primary molars treated with premixed bio-ceramic MTA versus formocresol for caries-related pulp therapy is under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Caries

Drugs mentioned

• Formocresol (Formocresol)
• premixed bio-ceramic MTA

Snippet

Sponsor: Sarah Abdelbar Mahmoud | Conditions: Caries | Phase 3 | Status: UNKNOWN